×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Ex-GW Pharma Bosses Lead Development of New CBD-Based Epilepsy Drug
Business of Cannabis
Avata Biosciences is developing solid dose cannabinoid medicines for epilepsy and other neurological disorders, with a number of former GW Pharmaceutical...
1 day ago
GW Pharma to Settle Jazz Pharma Buyout Suit for $7.5 Million
Bloomberg Law News
GW Pharmaceuticals and its leaders will pay $7.5 million to end shareholder allegations that they filed a deficient proxy statement to win...
1 month ago
Sativex (Nabiximols) for the Treatment of Multiple Sclerosis, Europe
Clinical Trials Arena
Sativex®, also known as Nabiximols, is indicated to treat spasticity due to multiple sclerosis and cancer pain.
2 months ago
Cannabinoid-based medicine Epidiolex OK'd for sale in Canada
MJBizDaily
(This story has been updated to correct the date of Jazz Pharmaceuticals' 2021 acquisition of GW Pharmaceuticals.).
5 months ago
Jazz looks at strategic options, including possible sale or unit divestiture: Bloomberg
Fierce Pharma
With a new chief operating officer and an ongoing generics hit to its longtime stalwart Xyrem, Jazz Pharma has been going through some...
7 months ago
The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Shire, Johnson & Johnson and Supernus Pharmaceuticals
Yahoo News Singapore
The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Shire, Johnson & Johnson and Supernus Pharmaceuticals.
1 week ago
Jazz Pharmaceuticals Is Said to Explore Options Including Sale
Bloomberg
Jazz Pharmaceuticals Plc is exploring strategic options including a potential sale, people with knowledge of the matter said.
7 months ago
Monteverde & Associates PC and Kahn Swick & Foti Announce Proposed Class Action Settlement on Behalf of Holders ...
PR Newswire
PRNewswire/ -- TO: RECORD AND BENEFICIAL HOLDERS OF GW PHARMACEUTICALS, PLC. ("GW") AMERICAN DEPOSITARY SHARES FROM MARCH 10, 2021 THROUGH...
8 months ago
CanG's Passage Drives Up Global Cannabis Stock Prices, & Jazz Pharma Pays $7.5m To Settle Lawsuit Over GW ...
Business of Cannabis
Yesterday, the President of Bundesrat, Manuela Schwesig, signed Germany's landmark CanG bill, meaning it is now all but certain to be...
1 month ago
Jazz Pharma to buy GW Pharma for $7.2 billion, adding cannabis-based drug to portfolio
Reuters
Jazz Pharmaceuticals Plc said on Wednesday it had agreed to buy GW Pharmaceuticals plc in a $7.2 billion cash-and-stock deal which will...
39 months ago